{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:07Z","timestamp":1789907647236,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11096-012-9676-5","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T02:58:07Z","timestamp":1342666687000},"page":"773-778","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital"],"prefix":"10.1007","volume":"34","author":[{"given":"Barbara O. M.","family":"Claus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fien M. R.","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Robays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"9676_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1258\/jhsrp.2007.007011","volume":"13","author":"J Karnon","year":"2008","unstructured":"Karnon J, McIntosh A, Dean J, Bath P, Hutchinson A, Oakley J, et al. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy. 2008;13:85\u201391.","journal-title":"J Health Serv Res Policy"},{"key":"9676_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.282.3.267","volume":"282","author":"LL Leape","year":"1999","unstructured":"Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267\u201370.","journal-title":"JAMA"},{"key":"9676_CR3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1592\/phco.27.4.481","volume":"27","author":"CA Bond","year":"2007","unstructured":"Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27:481\u201393.","journal-title":"Pharmacotherapy"},{"key":"9676_CR4","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/CCM.0b013e31818f2269","volume":"36","author":"R Maclaren","year":"2008","unstructured":"Maclaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184\u20139.","journal-title":"Crit Care Med"},{"key":"9676_CR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.seizure.2010.10.037","volume":"20","author":"I Minshall","year":"2011","unstructured":"Minshall I, Berry D, Smith D. The impact of an educational intervention, the New GP Contract and NICE guidelines on anti-epilepsy therapeutic drug monitoring. Seizure. 2011;20:126\u201330.","journal-title":"Seizure"},{"key":"9676_CR6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.1995.03530200058038","volume":"274","author":"RA Schoenenberger","year":"1995","unstructured":"Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW. Appropriateness of antiepileptic drug level monitoring. JAMA. 1995;274:1622\u20136.","journal-title":"JAMA"},{"key":"9676_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bmj.39090.709537.47","volume":"334","author":"WS Smellie","year":"2007","unstructured":"Smellie WS, Coleman JJ. Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin. BMJ. 2007;334:312\u20135.","journal-title":"BMJ"},{"key":"9676_CR8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874192401105010130","volume":"5","author":"GM Currie","year":"2011","unstructured":"Currie GM, Wheat JM, Kiat H. Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J. 2011;5:130\u20135.","journal-title":"Open Cardiovasc Med J"},{"key":"9676_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1445-5994.2008.01847.x","volume":"40","author":"NM Rogers","year":"2010","unstructured":"Rogers NM, Jones TE, Morris RG. Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriber. Intern Med J. 2010;40:52\u20136.","journal-title":"Intern Med J"},{"key":"9676_CR10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1081\/CLT-100102388","volume":"38","author":"HA Spiller","year":"2000","unstructured":"Spiller HA, Krenzelok EP, Klein-Schwartz W, Winter ML, Weber JA, Sollee DR, et al. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol. 2000;38:755\u201360.","journal-title":"J Toxicol Clin Toxicol"},{"key":"9676_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00019053-199712020-00007","volume":"12","author":"AJ Gandhi","year":"1997","unstructured":"Gandhi AJ, Vlasses PH, Morton DJ, Bauman JL. Economic impact of digoxin toxicity. Pharmacoeconomics. 1997;12:175\u201381.","journal-title":"Pharmacoeconomics"},{"key":"9676_CR12","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/ajhp\/61.24.2635","volume":"61","author":"W Harris","year":"2004","unstructured":"Harris W. Methotrexate-associated medication errors. Am J Health Syst Pharm. 2004;61:2635.","journal-title":"Am J Health Syst Pharm"},{"key":"9676_CR13","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/ajhp\/61.13.1380","volume":"61","author":"TJ Moore","year":"2004","unstructured":"Moore TJ, Walsh CS, Cohen MR. Reported medication errors associated with methotrexate. Am J Health Syst Pharm. 2004;61:1380\u20134.","journal-title":"Am J Health Syst Pharm"},{"key":"9676_CR14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000275198","volume":"220","author":"JH Saurat","year":"2010","unstructured":"Saurat JH, Guerin A, Yu AP, Latremouille-Viau D, Wu EQ, Gupta SR, et al. High prevalence of potential drug\u2013drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice. Dermatology. 2010;220:128\u201337.","journal-title":"Dermatology"},{"key":"9676_CR15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jaci.2003.11.032","volume":"113","author":"AJ Apter","year":"2004","unstructured":"Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, et al. Represcription of penicillin after allergic-like events. J Allergy Clin Immunol. 2004;113:764\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"9676_CR16","first-page":"79","volume":"51","author":"SL Preston","year":"1994","unstructured":"Preston SL, Briceland LL, Lesar TS. Accuracy of penicillin allergy reporting. Am J Hosp Pharm. 1994;51:79\u201384.","journal-title":"Am J Hosp Pharm"},{"key":"9676_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00019053-199813010-00004","volume":"13","author":"PM Beringer","year":"1998","unstructured":"Beringer PM, Wong-Beringer A, Rho JP. Economic aspects of antibacterial adverse effects. Pharmacoeconomics. 1998;13:35\u201349.","journal-title":"Pharmacoeconomics"},{"key":"9676_CR18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2146\/ajhp070506","volume":"65","author":"T Rijdt De","year":"2008","unstructured":"De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65:1161\u201372.","journal-title":"Am J Health Syst Pharm"},{"key":"9676_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1592\/phco.23.1.113.31910","volume":"23","author":"GT Schumock","year":"2003","unstructured":"Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence on the economic benefit of clinical pharmacy services: 1996\u20132000. Pharmacotherapy. 2003;23:113\u201332.","journal-title":"Pharmacotherapy"},{"key":"9676_CR20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2753.2006.00753.x","volume":"13","author":"C Scullin","year":"2007","unstructured":"Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13:781\u20138.","journal-title":"J Eval Clin Pract"},{"issue":"11","key":"9676_CR21","first-page":"1500","volume":"92","author":"C Ratanajamit","year":"2009","unstructured":"Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. J Med Assoc Thai. 2009;92(11):1500\u20137.","journal-title":"J Med Assoc Thai"},{"issue":"26","key":"9676_CR22","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1056\/NEJMp1111662","volume":"365","author":"SS Rauh","year":"2011","unstructured":"Rauh SS, Wadsworth EB, Weeks WB, Weinstein JN. The savings illusion\u2014why clinical quality improvement fails to deliver bottom-line results. N Engl J Med. 2011;365(26):e48.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-012-9676-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9676-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T06:39:00Z","timestamp":1561963140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-012-9676-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,19]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9676"],"URL":"https:\/\/doi.org\/10.1007\/s11096-012-9676-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,19]]}}}